More recently, one single KIT/PDGFRA WT GIST was identified to carry a KRAS mutation in codon 12 among 267 patients and associated with an aggressive behavior and resistance to multiple TKI inhibitors [10]. This evidence concerns the gene KRAS and gastrointestinal stromal tumor.